Aerobic Exercise Training and In Vivo Akt Activation Counteract Cancer Cachexia by Inducing a Hypertrophic Profile through eIF-2α Modulation

• Published in: Cancers Vol. 14; no. 1; p. 28
• Main Authors: Pereira, Marcelo G, Voltarelli, Vanessa A, Tobias, Gabriel C, de Souza, Lara, Borges, Gabriela S, Paixão, Ailma O, de Almeida, Ney R, Bowen, Thomas Scott, Demasi, Marilene, Miyabara, Elen H, Brum, Patricia C
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 22.12.2021; MDPI
• Subjects: Aerobics; AKT protein; Atrophy; Cachexia; Cancer; Chronic illnesses; Exercise; Fitness equipment; Fitness training programs; Gene therapy; Hypertrophy; Initiation factors; Kinases; Medical innovations; Medical prognosis; Morphology; Musculoskeletal system; Physical fitness; Physical training; Plasmids; Plasticity; Protein expression; Proteins; Public health; Skeletal muscle; Tumors; Brazil; United States > US; eIF-2α; cancer cachexia; translation initiation; Akt-induced hypertrophy; physical exercise; skeletal muscle plasticity; Akt/mTORC1 signaling
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers14010028

Cancer cachexia is a multifactorial and devastating syndrome characterized by severe skeletal muscle mass loss and dysfunction. As cachexia still has neither a cure nor an effective treatment, better understanding of skeletal muscle plasticity in the context of cancer is of great importance. Although aerobic exercise training (AET) has been shown as an important complementary therapy for chronic diseases and associated comorbidities, the impact of AET on skeletal muscle mass maintenance during cancer progression has not been well documented yet. Here, we show that previous AET induced a protective mechanism against tumor-induced muscle wasting by modulating the Akt/mTORC1 signaling and eukaryotic initiation factors, specifically eIF2-α. Thereafter, it was determined whether the in vivo Akt activation would induce a hypertrophic profile in cachectic muscles. As observed for the first time, Akt-induced hypertrophy was able and sufficient to either prevent or revert cancer cachexia by modulating both Akt/mTORC1 pathway and the eIF-2α activation, and induced a better muscle functionality. These findings provide evidence that skeletal muscle tissue still preserves hypertrophic potential to be stimulated by either AET or gene therapy to counteract cancer cachexia.